Abstract:Background Colorectal cancer (CRC) is the third most common cancer and the leading cause of cancer-related death worldwide. The high mortality of CRC is largely due to the late diagnosis, incomplete molecular understanding of pathological progression, and limited treatment options for patients with advanced disease stages. Therefore, the identification of novel biomarkers at the early (pre-cancerous) phase, thorough elucidation of pathological mechanisms, and development of effective therapies are crucial for CRC diagnosis and treatment. Methods As common precursors to colorectal cancer (CRC), polyps and adenomas in the large intestine may develop into malignancy over time through a cascade known as the 'normal-polyp-adenoma-carcinoma' sequence. To better understand the molecular mechanisms underlying the initiation and progression of CRC, we have utilized the 10× genomics scRNA-seq platform to perform a high-resolution transcriptomic analysis of three normal colorectal tissues, two samples with inflammatory polyps, two specimens with adenomatous polyps and three CRC samples (IDDF2024-ABS-0065 Figure 1. Sample collection and cell type identification). Results By analyzing the scRNA-seq data of the ten samples, in combination with validation by immunofluorescence staining using expanded clinical samples, and together with verification using large-scale TCGA and Kaplan–Meier data, we provided a dynamic landscape of ten clinical colorectal samples covering these four pathological phases, showed the heterogeneity of (sub-) cell types and difference of the transcriptomic profiling across the four stages (IDDF2024-ABS-0065 Figure 2. T cells, IDDF2024-ABS-0065 Figure 3. Treg cells, IDDF2024-ABS-0065 Figure 4. Epithelial cells, IDDF2024-ABS-0065 Figure 5. Fibroblasts), and demonstrated that ligand-receptor genes (IDDF2024-ABS-0065 Figure 1. Sample collection and cell type identification (F-H)), transcription factors (IDDF2024-ABS-0065 Figure 2. T cells (G,H,L,M), IDDF2024-ABS-0065 Figure 4. Epithelial cells (J-L), IDDF2024-ABS-0065 Figure 5. Fibroblasts (J-L)) and genes encoding multiple immunoglobulins and heat shock proteins (IDDF2024-ABS-0065 Figure 2. T cells (C), IDDF2024-ABS-0065 Figure 5. Fibroblasts (G)) may play distinct roles in immunity and microenvironment during colorectal malignancy. More importantly and for the first time, in-depth analyses showed that the expression of ligand-receptor genes can be used to determine the cell (sub-)types isolated from colorectal tissues (IDDF2024-ABS-0065 Figure 1. Sample collection and cell type identification). Conclusions Our transcriptome data provides valuable insights and a useful resource for better understanding the molecular pathological landscape in CRC to achieve more effective diagnosis and treatments.

Genome-wide profiling of active enhancers in colorectal cancer

Genome-wide Profiling in Colorectal Cancer Identifies PHF19 and TBC1D16 As Oncogenic Super Enhancers

Genome-Wide Methylation Profiling of lncRNAs Reveals a Novel Progression-Related and Prognostic Marker for Colorectal Cancer

Multi-omics Analysis to Identify Susceptibility Genes for Colorectal Cancer.

Super-Enhancer Induced IL-20RA Promotes Proliferation/Metastasis and Immune Evasion in Colorectal Cancer

Epigenomic Landscape of 5-Hydroxymethylcytosine Reveals Its Transcriptional Regulation of Lncrnas in Colorectal Cancer

Genome-wide enhancer-gene regulatory maps link causal variants to target genes underlying human cancer risk

Genome-Wide Enhancer Analysis Reveals the Role of AP-1 Transcription Factor in Head and Neck Squamous Cell Carcinoma

Comprehensive characterization genetic regulation and chromatin landscape of enhancer-associated long non-coding RNAs and their implication in human cancer

Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Dynamic Chromatin States Coupling with Key Transcription Factors in Colitis‐Associated Colorectal Cancer

Single-cell chromatin accessibility analysis reveals the epigenetic basis and signature transcription factors for the molecular subtypes of colorectal cancers

Cooperation of MLL1 and Jun in controlling H3K4me3 on enhancers in colorectal cancer

IDDF2024-ABS-0065 A Dynamic Molecular Landscape at Single-Cell Resolution and the Importance of Ligand-Receptor Genes Through the Progression of Colorectal Cancer

TP63, SOX2 and KLF5 Establish Core Regulatory Circuitry and Construct Cancer Specific Epigenome in Esophageal Squamous Cell Carcinoma

CenhANCER: a comprehensive cancer enhancer database for primary tissues and cell lines

Enhancer methylation dynamics drive core transcriptional regulatory circuitry in pan-cancer

Integrative single-cell analysis of human colorectal cancer reveals patient stratification with distinct immune evasion mechanisms

Comprehensive profiling of extrachromosomal circular DNAs in colorectal cancer progression

The Hyper-Activation of Transcriptional Enhancers in Breast Cancer.

Cancer CRC: A Comprehensive Cancer Core Transcriptional Regulatory Circuit Resource and Analysis Platform